Menu
GWAS Study

GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.

Cruchaga C, Kauwe JS, Harari O et al.

23562540 PubMed ID
GWAS Study Type
1278 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CC
Cruchaga C
KJ
Kauwe JS
HO
Harari O
JS
Jin SC
CY
Cai Y
KC
Karch CM
BB
Benitez BA
JA
Jeng AT
ST
Skorupa T
CD
Carrell D
BS
Bertelsen S
BM
Bailey M
MD
McKean D
SJ
Shulman JM
DJ
De Jager PL
CL
Chibnik L
BD
Bennett DA
AS
Arnold SE
HD
Harold D
SR
Sims R
GA
Gerrish A
WJ
Williams J
VD
Van Deerlin VM
LV
Lee VM
SL
Shaw LM
TJ
Trojanowski JQ
HJ
Haines JL
MR
Mayeux R
PM
Pericak-Vance MA
FL
Farrer LA
SG
Schellenberg GD
PE
Peskind ER
GD
Galasko D
FA
Fagan AM
HD
Holtzman DM
MJ
Morris JC
GA
Goate AM
Chapter II

Abstract

Summary of the research findings

Cerebrospinal fluid (CSF) tau, tau phosphorylated at threonine 181 (ptau), and Aβ₄₂ are established biomarkers for Alzheimer's disease (AD) and have been used as quantitative traits for genetic analyses. We performed the largest genome-wide association study for cerebrospinal fluid (CSF) tau/ptau levels published to date (n = 1,269), identifying three genome-wide significant loci for CSF tau and ptau: rs9877502 (p = 4.89 × 10⁻⁹ for tau) located at 3q28 between GEMC1 and OSTN, rs514716 (p = 1.07 × 10⁻⁸ and p = 3.22 × 10⁻⁹ for tau and ptau, respectively), located at 9p24.2 within GLIS3 and rs6922617 (p = 3.58 × 10⁻⁸ for CSF ptau) at 6p21.1 within the TREM gene cluster, a region recently reported to harbor rare variants that increase AD risk. In independent data sets, rs9877502 showed a strong association with risk for AD, tangle pathology, and global cognitive decline (p = 2.67 × 10⁻⁴, 0.039, 4.86 × 10⁻⁵, respectively) illustrating how this endophenotype-based approach can be used to identify new AD risk loci.

591 European ancestry cases, 687 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

1278
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S., Canada
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.